Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus During the First 3 Months Post Kidney Transplant (the myFORTic Study).

Trial Profile

Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus During the First 3 Months Post Kidney Transplant (the myFORTic Study).

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 17 Nov 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Mycophenolate sodium (Primary) ; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics
  • Acronyms myFORTic

Most Recent Events

  • 01 May 2012 Status changed from completed to recruiting as reported by European Clinical Trials Database (EudraCT2008-006072-30).
  • 01 May 2012 Status changed from completed to recruiting as reported by European Clinical Trials Database (EudraCT2008-006072-30).
  • 26 Mar 2010 Actual end date added to 1 Mar 2010 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top